De richtlijnendatabase is de centrale plek voor evidence based richtlijnen van alle specialismen.
Ontwikkeld door medisch specialisten gelieerd aan de wetenschappelijke verenigingen en het Kennisinstituut van de Federatie Medisch Specialisten.
Zoeken
495 resultaten voor 'where to buy 复方黄柏液'
-
Generieke richtlijnmodule gepast opioïdengebruik
- Generieke richtlijnmodule gepast opioïdengebruik
- 75 mg, P < 0.001) M: 225 mg to 150 mg, P= 0.85 LA: 150 mg to 94 mg, P < 0.001 LC: 150 mg to 82 mg, P < 0.001 OUHR: 150 mg to 103 mg, P < 0.001 OIHR: 175
- Some concerns Due to blinding, and loss to follow-up.
- prescription) compared to a higher primary prescription volume.
- A systematic review of the literature was performed to answer the following question: What is the effectiveness of ‘an intervention for appropiate opioids
- Dit evidence-to-decision framework is een integraal onderdeel van de GRADE-methodiek.
- Startpagina - Generieke richtlijnmodule gepast opioïdengebruik
- Dit evidence-to-decision framework is een integraal onderdeel van de GRADE-methodiek.
- Generieke richtlijnmodule gepast opioïdengebruik
-
UWI bij kinderen
- Beeldvorming VUR en andere structurele afwijkingen
- De number needed to detect werden niet gegeven, en graad II werd ook als relevante uitkomstmaat gerekend.
- Cut-off point(s): Timing unclear Describe reference test: All tests performed protocol, where US, VCUG and late DMSA scan are theoretically performed on
- afwijkingen (VUR en littekens) Redelijk GRADE De top down approach (TDA) geeft waarschijnlijk de hoogste sensitiviteit (85%) met de hoogste number needed to
- De betrouwbaarheid van de test, de belasting en kosten ervan per patiënt en number needed to detect en de gevolgen van het initieel missen van de diagnose
- De testeigenschappen en de number needed to detect, die afhankelijk is van de vooraf kans, worden meegenomen in de besluitvorming.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Parenchymafwijkingen risicofactor complicaties
- Verrichten DMSA (Number needed to detect) met nadelen belasting en stralenblootstelling (gering) Als nog geen MCUG verricht, alsnog overwegen om VUR op
- Users' guides to the medical literature. How to use an article about prognosis. Evidence-Based Medicine Working Group.
- VUR Bij de overwegingen worden bovenstaande voor- en nadelen uit tabel 1 meegewogen en afgezet tegen de number needed to detect van DSMA in verschillende
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Interventies bij VUR
- Patiënten waarbij 2 of meer UWIs optraden binnen 6 maanden werden beschouwd als therapie falen en uit de studie verwijderd volgens intention-to-treat principe
- 5 (unlikely/likely/unclear) Bias due to violation of intention to treat analysis?
- profylaxe Hoewel de getallen van Nagler groot zijn is er veel heterogeniteit tussen de studies, er is veel laaggradige reflux geïncludeerd, intention-to-treat
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Epidemiologie
- levensjaar (To, 1998).
- Bronnen: (Craig, 1996; Herzog, 1989; Schoen, 2000; Singh-Grewal, 2005; Wiswell, 1989; Wiswell, 1985; To, 1998) - GRADE Er werd geen bewijs of te weinig
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Empirische behandeling antibiotica
- antibiotica Vazouras (2018) vond een microbiologisch genezingspercentage van 97.3% (95% BI 98,7 tot 98,6) van alle antibiotica, gemeten in de intention to
- No differences were observed for persistent bacteriuria, recurrence or re-infection between short and long-course antibiotics where the antibiotic differed
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Lange termijn gevolgen en follow up UWI
- adult follow-up clinic due to clinical risk for complication: renal scarring 54/111, predisposition to UTI 57/111.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Parenchymafwijkingen nieren na UWI
- Het non-VUR cohort (CUTIE-trial) includeerde 176 kinderen (10% lost to follow-up) zonder VUR na een eerste/tweede UWI.
- Users' guides to the medical literature. How to use an article about prognosis. Evidence-Based Medicine Working Group.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Opvangmethoden urine bij kinderen
- Een prospectieve studie (Ho, 2014) beschreef contaminatie van 5% onder niet-zindelijke kinderen, echter met hoge loss to follow-up.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Kans op VUR en andere anatomische afwijkingen bij een normale prenatale echo
- totaal werden 508 kinderen geïncludeerd, waarvan 387 de volledige diagnostiek had gehad (met name bij de DMSA op 6 maanden waren veel patiënten lost-to-follow-up
- of 77% (95% CI 69% to 85%) If pathogen E Coli: probability high grade VUR 3%, if ultrasound normal this decreases to 1%.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Profylaxe na een UWI
- : 1.20 (0.68 to 2.11) E: 1.37 (0.66 to 2.87) F: 0.62 (0.27 to 1.42) G: 0.81 (0.42 to 1.56) H: 0.35 (0.19 to 0.67) Pooled effect (random effects model):
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Beeldvorming VUR en andere structurele afwijkingen
-
Medicamenteuze behandeling zeerhoogrisico patiënten DM2
- Stappenplan
- Results (effects of interventions) All results refer to the addition of SGLT2 inhibitors and GLP-1 receptor agonists to existing diabetes treatment.
- Yes/no/unclear Enough similarities between studies to make combining them reasonable?
- on MACE, acute kidney failure (sudden loss of kidney function requiring hospitalization) and composite renal outcome (40% reduction in eGFR relative to
- These numbers needed to treat correspond to the thresholds used for broadly accepted treatments such as treatments with antihypertensive or cholesterol-lowering
- De number needed to treat (NNT 5 jaar) is weergegeven voor de afzonderlijke uitkomstmaten.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- SGLT2-remmers
- Results (effects of interventions) All results refer to the addition of SGLT-2 inhibitors to existing diabetes treatment.
- Yes/no/unclear Enough similarities between studies to make combining them reasonable?
- on MACE, acute kidney failure (sudden loss of kidney function requiring hospitalization) and composite renal outcome (40% reduction in eGFR relative to
- These numbers needed to treat correspond to the thresholds used for broadly accepted treatments such as treatments with antihypertensive or cholesterol-lowering
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- GLP-1 receptoragonisten
- Results (effects of interventions) All results refer to the addition of GLP-1 receptor agonists to existing diabetes treatment.
- Yes/no/unclear Enough similarities between studies to make combining them reasonable?
- on MACE, acute kidney failure (sudden loss of kidney function requiring hospitalization) and composite renal outcome (40% reduction in eGFR relative to
- These numbers needed to treat correspond to the thresholds used for broadly accepted treatments such as treatments with antihypertensive or cholesterol-lowering
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Stappenplan
-
Hevig menstrueel bloedverlies (HMB)
- HMB: Ablatie: 1e versus 2e generatie
- geen significant verschil in het percentage vrouwen met amenorroe tussen eerste (36.4%) en tweede (36.2%) generatie ablatietechnieken; OR 1.12 (0.93 to
- 5 to 19), five studies).
- (yr="2010 -Current" and english) (103) 22 Zoekfilter SR (11) 51 Zoekfilter RCT – Cochrane (54) 81 Embolization, Therapeutic/ (20766) 82 limit 81 to yr
- Na bipolaire radio frequency ablatie hebben meer vrouwen een amenorroe dan na thermische ballon ablatie (OR 4.56, 95% CI 2.24 to 9.26; p<0.001) (Daniels
- HMB: LNG-IUD versus endometriumablatie
- at presentation, pathological causes of HMB, primary use of progesterone-releasing intrauterine system for any other reason than HMB, and conditions where
- progesterone-releasing intrauterine system for any reason other than heavy menstrual bleeding for example contraception or relief of climacteric symptoms; conditions where
- bleeding without myomas/adenomyosis were satisfied at three and six months after receiving the levonorgestrel-releasing intrauterine device as compared to
- Recovery time is the time from start of treatment to resumption of work/daily activities.
- HMB: Ablatie versus hysterectomie
- OR 16.7 (5.8 to 48.6) (Lethaby et al., 2010).
- 5 to 19), five studies).
- (yr="2010 -Current" and english) (103) 22 Zoekfilter SR (11) 51 Zoekfilter RCT – Cochrane (54) 81 Embolization, Therapeutic/ (20766) 82 limit 81 to yr
- HMB: Voorbehandeling TCRM
- Het was onduidelijk of er loss to follow-up was.
- duration in minutes (SD) I: mean 15.9 minutes (SD 3.1) C: mean 21.3 minutes (SD 4.0) Data was primarily extracted from the Lethaby 2017 Cochrane review, where
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- HMB: Hysterectomie versus LNG-IUD
- hysterectomie ondergingen even tevreden als vrouwen die een LNG-IUD kregen (5.3% versus 17.2% ontevreden (23/432 versus 22/128); OR 2.22; 95% CI 0.94 to
- 5 to 19), five studies).
- (yr="2010 -Current" and english) (103) 22 Zoekfilter SR (11) 51 Zoekfilter RCT – Cochrane (54) 81 Embolization, Therapeutic/ (20766) 82 limit 81 to yr
- HMB: Embolisatie versus chirurgie bij myomen
- waren significant meer re-interventies uitgevoerd in de embolisatie groep (64/271, 23%) vergeleken met de chirurgie groep (12/215, 6%); OR 5.64 (2.92 to
- 5 to 19), five studies).
- (yr="2010 -Current" and english) (103) 22 Zoekfilter SR (11) 51 Zoekfilter RCT – Cochrane (54) 81 Embolization, Therapeutic/ (20766) 82 limit 81 to yr
- HMB: Voorbehandeling myomectomie
- In de interventiegroep waren 2 deelnemers lost to follow-up (n=1 CDB10; n=1 CDB20), in de controlegroep waren 2 deelnemers lost to follow-up en 2 deelnemers
- Three trials where laparoscopic myomectomy was performed had mixed results; two trials reported that GnRHa pretreatment reduced blood loss by either37
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- MRgFUS versus hysterectomie bij vrouwen met myomen
- Only in the discussion the review sought to include studies about hysterectomy to be able to broadly compare. No comparison in the results section.
- The werkgroep definieerde de klinische afkapwaardes als volgt: re-interventies: een 10% risico verschil (RV) of number needed to treat (NNT) van 10; hersteltijd
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Laparoscopische versus laparotomische myomectomie bij vrouwen met myomen
- both groups) H: 1.17 (0.42 to 3.23) Pooled effect (RR, random effects model): 1.10 (0.69 to 1.75) favoring open (mini) myectomy Heterogeneity (I2): 0%
- The werkgroep definieerde de klinische afkapwaardes als volgt: re-interventies: een 10% risico verschil (RV) of number needed to treat (NNT) van 10; hersteltijd
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- HMB: TCRM versus hysterectomie bij myomen
- 5 to 19), five studies).
- (yr="2010 -Current" and english) (103) 22 Zoekfilter SR (11) 51 Zoekfilter RCT – Cochrane (54) 81 Embolization, Therapeutic/ (20766) 82 limit 81 to yr
- HMB: Ablatie: 1e versus 2e generatie
-
Nierpreservatie bij postmortale nierdonatie
- Machineperfusie na een periode van statisch koud bewaren
- Between organ retrieval and transplantation, deceased donor kidneys need to be stored for several hours (organ preservation), as time is needed for transport
- The reported RD was -4.5 (95% CI, -15.1 to 6.1), which is in favor of the SCS + end-HMPO2 group, but was considered not clinically relevant.
- To pump or not to pump: a comparison of machine perfusion vs cold storage for deceased donor kidney transplantation.
- Delayed graft function (critical) Moderate GRADE Kidney transplantation following SCS and end-HMPO2 likely results in little to no difference in delayed
- A systematic review of the literature was performed to answer the following question: What are the (un)beneficial effects of static cold storage and hypothermic
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Geoxygeneerde machineperfusie versus niet-geoxygeneerde machineperfusie
- It is important to know whether adding oxygen to HMP also leads to better kidney transplant outcomes in the clinical, human setting than using HMP without
- The risk difference was 0 (95% CI -14 to 14). This means that there was no difference between the two groups of patients.
- CI 0.85 to 0.96) -6 months I: 0.97 (95% CI 0.91 to 0.99) C: 0.91 (95% CI 0.83 to 0.95) -12 months I: 0.97 (95% CI 0.91 to 0.99) C: 0.89 (0.82 to 0.94)
- Delayed graft function (DGF) (critical) Low GRADE Kidney transplantation following oxygenated machine perfusion may result in little to no difference in
- A systematic review of the literature was performed to answer the following question: What are the (un)beneficial effects of oxygenated kidney preservation
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Niet-geoxygeneerde machineperfusie versus statisch koud bewaren
- retrieval and transplantation, deceased-donor kidneys must be stored for several hours (organ preservation), as time is needed for transport from donor to
- Organ donors had to be 16 years of age or older.
- Inclusion criteria: DCD donors which where Maastricht category III; organ donors had to be at least 16 years of age Exclusion criteria: Not reported N
- in recipients of deceased-donor kidneys compared to static cold storage?
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Machineperfusie voor het verlengen van de preservatieduur
- Being able to postpone a kidney transplant to daytime surgery by extended preservation can be beneficial for the allocation, logistics and sustainability
- A systematic review of the literature was performed to answer the following question: What are (un)favorable effects of extending the preservation time
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Preservatiemethode
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Machineperfusie na een periode van statisch koud bewaren
-
Prostaatcarcinoom
- Gecombineerde therapie bij nieuw gediagnosticeerd gemetastaseerd prostaatcarcinoom
- The increased risk of complications/side effects corresponds to 162 more (105 more to 224 more) grade III to V adverse events per 1000 men after a median
- Please see Table 2 to 6.
- Clinical question (ENG) What is the role of ADT combined with an androgen receptor signaling inhibitor (ARSI) or chemotherapy or radiation compared to
- Low volume Compared to ADT alone, the addition of Docetaxel to ADT probably results in little or no increase in overall survival in patients with low-volume
- events, time to pain progression, and time to chemotherapy.
- Seksuologisch revalidatieprogramma
- evaluated in a prospective observational study a combined penile and sexual rehabilitation program with a clinical sexologist (study group) compared to
- psychologische interventies) 1.6 Clinical question (ENG) What is the role of a sexual rehabilitation program in prostate cancer patients after cancer treatment to
- very uncertain about the effect of a combined penile and sexual rehabilitation program on having regular sexual activity with penetrating sex, compared to
- A systematic review of the literature was performed to answer the following question: What are the (un)favourable effects of sexual rehabilitation in prostate
- Lymfeklierdissectie of bekkenbestraling bij cTxN1M0
- The mean/median age in the selected studies ranged from 64.1 to 69 years. The mean/median length of follow-up ranged from 2.5 to 7.5 years.
- ADT alone RP 0.32 (016-0.66) Compared to RT + ADT RP 0.47 (0.19-1.17) All-cause mortality Compared to ADT alone RP 0.36 (0.21-0.61) Compared to RT + ADT
- Pelvic irradiation with LT vs ADT only Overall Survival Very low GRADE It is unclear what the effect is of RT with/without ADT, as compared to ADT alone
- A systematic literature review was conducted to answer the following question: What are the (un)favorable effects of pelvic lymph mode dissection or pelvic
- Eerstelijnsbehandeling CRPC
- PREVAIL study 0.71 (0.60 to 0.84) 0.19 (0.15 to 0.23) No long term follow up performed.
- Loss-to-follow-up: Intervention: no losses to follow up Control: no losses to follow up.
- life Moderate GRADE Radioligand therapy versus placebo probably results in a not clinically relevant change in quality of life at follow up compared to
- The new literature (2014-2021) is added to the literature from the original module published in 2016.
- Verwijzing naar seksuologisch geschoolde hulpverlener
- Clinical question (ENG) When should patients with prostate cancer be referred to a sexual health professional?
- No search question was formulated to answer the clinical question ‘When should patients with prostate cancer be referred to a sexual health professional
- Seksuele Gezondheid
- I What is the role of a sexual rehabilitation program in prostate cancer patients after cancer treatment to improve sexual health?
- Bevorderen seksuele gezondheid
- Clinical question (ENG) How should sexual health in prostate cancer patients be addressed and improved and what topics have to be discussed with the patient
- Diagnostische prostaat MRI
- 0.37) 0.91 (0.83 to 0.95) 0.37 (0.29 to 0.46) P < 0.01f 0.29 (0.22 to 0.38) 0.91 (0.86 to 0.94) 0.38 (0.36 to 0.40) MRI-pathway 2257 (8) 0.29 (0.24 to
- 6 Yes/no/unclear Enough similarities between studies to make combining them reasonable?
- Oligometastasen
- De intention to treat analyse liet zien dat het verschil in ADT-vrije overleving tussen beide groepen significant verschilde, Hazard Ratio (HR)= 0,60 (
- 4 (unlikely/likely/uncle ar) Bias due to loss to follow-up?5 (unlikely/likely/uncle ar) Bias due to violation of intention to treat analysis?
- Lokaal recidief
- To answer the clinical question, a systematic literature analysis was carried out to answer the following research question: What are the effects of the
- Gecombineerde therapie bij nieuw gediagnosticeerd gemetastaseerd prostaatcarcinoom
-
Developmental Coordination Disorder (DCD)
- Activiteiten- en participatiegerichte behandelingen
- onderzochte activiteiten- of participatie-gerichte behandelingen zijn: Taak-specifieke training NTT (Neuromotor Task Training) CO-OP (Cognitive Orientation to
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- DCD en ketenzorg
- gedragen geïmplementeerd kan worden. 6.4 Creëer binnen de regio een werkgroep met betrokken disciplines, die als taak heeft de regionale afspraken up-to-date
- In elk regionaal netwerk voor ketenzorg rond kinderen met DCD is het van belang dat de kennis up-to-date is.
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Diagnose stellen
- criteria die vermeld staan in de DC:0-5tm (Diagnostic Classification of Mental Health and Developmental Disorders of Infancy and Early Childhood) (ZERO TO
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- DCD: Definitie en achtergronden
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- DCD: Beoordeling en monitoring
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Anamnese afnemen
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- DCD-vragenlijsten
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Beoordelen motorische vaardigheden
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Comorbiditeit en DCD
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- DCD: Psychosociale aspecten
- How to identify existing literature on patients' knowledge, views, and values: the development of a validated search filter.
- Activiteiten- en participatiegerichte behandelingen
-
Inflammatoire darmziekten volwassenen
- Mild tot matig ernstige pancolitis ulcerosa
- 5-ASA lijkt in vergelijking met SASP een trend tot betere effectiviteit te hebben (OR 0.83 voor falende therapie (95% CI 0.60 to 1.13) (Sutherland, 2006
- Behandeling van perianale fistels bij de ziekte van Crohn
- Tevens is er een uitvalspercentage (lost to follow up) van 35-40% in beide groepen op een jaar follow-up.
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- Het wordt gebruikt als ‘stand-alone’ therapie of als ‘add-on to surgery’ en is geënt op zijn regeneratieve eigenschappen en mogelijkheid tot (ondersteunen
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Type chirurgische ingreep per indicatie
- Er zijn aanwijzingen, dat een (gestapelde) side-to-side anastomose (functionele end-to-end) te prefereren is boven een end-to-end anastomose wat betreft
- anastomosen (functionele endto-end) een lager recidiefpercentages geeft dan end-to-end anastomose.
- Behandeling van patiënten met een maligniteit in het verleden
- a population where the patient and physicians were comfortable with re-initiation of therapy.
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Behandeling van vermoeidheid
- (unlikely/likely/unclear) Bias due to violation of intention to treat analysis?
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Dieet
- If they remained in remission, the prednisolone dose was reduced to 30mg after 1 week, to 20mg after 1month, and to 10mg after 2months, and withdrawn after
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- IBD-medicatie tijdens zwangerschap
- Control (treatment): Exposed to anti-TNF (C1) or not exposed to both immunomodulatory or biologicals during pregnancy (C2).
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Medicamenteuze behandeling van patiënten >60 jaar
- Loss-to-follow-up: None.
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Voedingssupplementen
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Preoperatief beleid bij medicamenteuze behandeling ziekte van Crohn
- schrijven aan een dieetbehandelings-richtlijn Geen Geen Van Dijk Diëtist, UMC Utrecht MDL-netwerk diëtisten (onbetaald, o.a. dieetbehande-lingsrichtlijn up to
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Mild tot matig ernstige pancolitis ulcerosa
-
Leeftijdsgebonden Maculadegeneratie (LMD)
- OCT-angiografie
- patients, compared to FA.
- A case control design is very likely to overestimate accuracy and thus introduce bias. Inappropriate exclusion is likely to introduce bias.
- OCT, FA, and/or multimodal imaging seems comparable to detect CNV in patients with AMD.
- Critical Inconclusive outcome Patient is subjected to other diagnostic tests, but will get treatment according to the guideline Important Search and select
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Criteria voor het veranderen van anti-VEGF middel
- monotherapy due to persistent or resistant exudative fluid secondary to nAMD were included.
- to 7.25] H: -0.19 [-1.77 to 1.39] K: -0.55 [-0.58 to -0.52] N: 1 [-1.99 to 3.99] O: -0.75 [-1.43 to -0.07] Q: -2.55 [-7.28 to 2.78] R: -0.5 [-3.31 to
- Visual acuity Very low GRADE The evidence is very uncertain about the effect of switching anti-VEGF on the (change in) visual acuity when compared to continuing
- A systematic review of the literature was performed to answer the following question: What is the effect of switching to other anti-VEGF in patients with
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Criteria om te stoppen met anti-VEGF behandeling
- to 68.8) letters at 12 months and to 65.8 (SD = 18.4; CI = 63.8 to 67.7) letters at 24 months of follow-up.
- Time to recurrent Not repod 2.
- time to recurrent when compared with continuation of bevacizumab in patients with neovasular/exsudative macular degeneration.
- A systematic review of the literature was performed to answer the following question: What are the (un)favorable effects of (temporary) discontinuation
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Behandelstrategie voor anti-VEGF medicatie
- The total number of participants was 7732, ranging from 37 to 2457 in each trial.
- The possibility to extend the interval between treatments was limited to 2 attempts.
- Visual acuity Low GRADE A treat-and-extend regimen may result in little to no difference in visual acuity when compared with monthly doses in patients
- and visual acuity, compared to standard care in patients with age-related macular degeneration?
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Keuze van anti-VEGF middel
- Brolucizumab-treated eyes were noninferior to aflibercept-treated eyes, and these visual gains were maintained to week 96.
- number was not communicated to unmasked staff.
- Vision maintenance/improvement Ranibizumab versus bevacizumab High GRADE Ranibizumab results in little to no difference in vision maintenance/improvement
- What is the effect of bevacizumab and aflibercept compared to any other anti-VEGF in patients with exudative age-related macular degeneration on vision
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Bloedverdunners bij LMD
- - GRADE It was not possible to draw conclusions or grade the level of evidence, due to the absence of comparative data. Source: -
- systematic review of the literature is uitgevoerd om de volgende vraag te beantwoorden: Is stopping or changing antiplatelet and anticoagulant drugs effective to
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Voedingsadvies ter preventie van LMD progressie
- Reference Bias due to confounding Bias in selection of participants into the study Bias in classification of interventions Bias due to deviations from
- Sources: Heus, 2020 (Chapman 2019) Low to Very low GRADE Van de volgende voeding(sstoffen) is een effect op de progressie van LMD onduidelijk: calcium,
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Photodynamic therapy bij retinale angiomateuze proliferatie
- The mean (range) visual acuity in the triamcinolone plus PDT group was 0.92 (0.15 to 1.6) logMAR at baseline and changed to 0.61 (0.15 to 1.6) logMAR at
- 0.63 (0 to 1.9) logMAR C: 0.85 (0.1 to 1.9) logMAR Retinal thickness Median (IQR) central retinal thickness I (1): 195 (175 to 220) μm I (2): 195 (175
- A systematic review of the literature was performed to answer the following question: What is the effect of Photodynamic Therapy (PDT), with or without
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Photodynamic therapy bij polypoidale choroidale vasculopathie
- The follow-up period ranged from 6 to 13 months.
- Literature search up to February 2020.
- A systematic review of the literature was performed to answer the following question: What is the effect of Photodynamic Therapy (PDT), with or without
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- Leefstijladviezen ter preventie van LMD progressie
- Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye, 22(6), 751-760.
- to patients with AMD.
- Het Maasstad Ziekenhuis nam deel aan de Raven studie van Novartis to 2020.
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.
- OCT-angiografie
-
Leidraad Behandeling van Patiënten met Multimorbiditeit op de Polikliniek
- Overkoepelende, integrale behandeling op maat bij Multimorbiditeit
- Neem in deze evaluatie het volgende mee: Time to benefit: tijd tussen de start van een behandeling en het moment van het optreden van de voordelen van
- De werkgroep adviseert aan alle behandelaren om voor de patiënt met meerdere chronische aandoening de volgende overwegingen mee te nemen: Time to benefit
- Toename in chronische ziekten en multimorbiditeit [Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general
- Herkenning van patiënten die gebaat zijn bij een overkoepelende, integrale behandeling op maat die rekening houdt met Multimorbiditeit
- Toename in chronische ziekten en multimorbiditeit [Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general
- Multidisciplinaire samenwerking
- Toename in chronische ziekten en multimorbiditeit [Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general
- Overkoepelende, integrale behandeling op maat bij Multimorbiditeit